Schematic representation of the progress in the development of vaccines against the most recent pandemic and seasonal H1N1 influenza virus strains. Schematic.

Slides:

Advertisements

Similar presentations

Implementing Expanded Seasonal Influenza Meeting Healthcare and Other Settings.

Advertisements

Vaccines and Related Biological Products

Seasonal flu vaccination programme (2010/2011) September 2010 Dr Syed Ahmed Consultant in Public Health Medicine and Immunisation Coordinator NHS Greater.

Andrew Pelletier, MD, MPH Maine Department of Health and Human Services June 26, 2006 Pandemic Influenza.

2012–2013 Influenza Season Epidemiology Lynn Sosa, MD Deputy State Epidemiologist Connecticut Department of Public Health 1.

H1N1: “Swine Flu”. Why you should care… Every year between 5 and 20% of the population gets the flu. The CDC estimates that the flu kills 36,000 people.

Developing a vaccine and how a pandemic could occur.

Risk of HPC Investment vs Return on HPC Investment April 1, 2015 Kim F. Wong Center for Simulation and Modeling University of Pittsburgh.

Review and Discussion Time line courtesy of:

Food and Drug Administration

Swine Flu Presenter: Ali Azarashk. Overview Introduction Classification History Transmission Signs and Symptoms Treatment.

H1N1 Virus (Swine Flu) By: Emalee Ramirez & Ashley Towe.

Agree Disagree 1._______ ________ 2._______ ________ 3._______ ________ 5._______ ________ 4._______ ________ An epidemic is worse than a pandemic. The.

Influenza biology and epidemiology. The course of illness  Symptoms  Fever, headache, body aches, fatigue  Cough, sore throat, runny nose  Duration:

Pandemic Vaccines Current and Future Issues 30 January 2007 Beijing Keiji Fukuda Global Influenza Programme.

Seasonal and Pandemic Influenza Research Activities National Vaccine Advisory Committee Meeting September 27, 2006 Barbara L. Mulach, Ph.D. National Institute.

What Is H1N1 (Swine Flu) Pandemic Influenza? Colorized image of H1N1 from a transmission electron micrograph. Source: CDC.

Developing a Vaccine to Protect Against Pandemic Influenza Public Statement by GlaxoSmithKline 27 February 2007.

Copenhagen, 5 March 2015 Identification of the most immunogenic/protective VLP-HA construct in mice Department of Immunology Development of a universal.

Influenza Virus Vaccine Strain Selection Vaccines and Related Biological Products Advisory Committee (2/22/2010) Jerry P. Weir, Ph.D., Director.

1 H5N1 Influenza Virus Vaccine, A/Vietnam/1203/2004 (Clade 1) VRBPAC Presentation Kenneth P. Guito, MBA Strategic Project Office.

Epidemiology of Swine Influenza H1N1 Amman 5/5/2009 Dr. Labib Sharif Associate Prof. Of Epidemiology Faculty of Veterinary Medicine Jordan University of.

“The Flu” influenza Diseases Unit Health Science Mr. Sheldon.

May 2011 Influenza in the UK ( ) HPA Report ‘Surveillance of influenza & other respiratory viruses in the UK’ (May 2011)

Area Covered. Work Done Quantity Financial Progress of work.

Higher Affinity Heptapeptides Against Influenza Hemagglutinin-Sialic Acid Identification for Treating Flu Virus Disease Ahmed ”e” Al Qaffas.

Copyright © 2017 American Academy of Pediatrics.

Category: Vaccines Market Report

Copyright © 2014 American Medical Association. All rights reserved.

Reassortment of influenza virus strains (antigenic shift) resulting in new strains. Reassortment occurs when two closely related segmented viruses infect.

Recommended Timeline for Influenza Vaccinations

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Vaccine effectiveness – 2017/18

Is it Flu? Advances in Diagnostic Strategies and Implications for Patient Care.

Keith Hamilton OIE Scientific and Technical Department, OIE Paris

Virology Select Cell Volume 141, Issue 2, (April 2010)

KEY CONCEPT Some viral diseases can be prevented with vaccines.

What’s new in 2010? (cont) New PCV 13 recommendations

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Schematic representation of the MAT loci of S. pombe, P. jirovecii, P

Case presentation of non-clinical and clinical development of vaccines

Human- Environment Interaction

Influenza: Options to Improve Pandemic Preparation

The Role of NICs in Influenza Surveillance

Planning for Pandemic Influenza

Annals of Emergency Medicine Volume 61, Issue 5, Pages (May 2013)

Laura Viviani, Baroukh M. Assael, Eitan Kerem

Viral Diseases How do vaccines work?.

Volume 124, Issue 4, Pages (February 2006)

Influenza Pandemic: A Threats to Regional and National Health and Development CSRU, SEARD.

Seasonal H1N influenza virus infection is associated with elevated pre‐exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus M.

Prevention of Swine Flu

Matthew S. Miller, Peter Palese Cell

Timeline of major events in influenza vaccine development.

Phylogenetic tree of Leclercia spp

Seasonal Flu & the H1N1 Virus What you need to know!

Finnian Hanrahan Infectious diseases and public health

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Chimeric HA-based universal influenza virus vaccine concept.

CANINE INFLUENZA VIRUS VACCINATION PROTOCOLS

Adenovirus - cause of the common cold

Schematic representation of the immunization regimens used in this study. Schematic representation of the immunization regimens used in this study. BALB/c.

Positions of amino acids in NA that have changed since 2009.

Simplified representation of the reverse genetic approach used to construct the chimera vaccine Poulvac FluFend i AI H5N3 RG to protect poultry against.

LAIV and WT influenza virus infection similarly enhance 19F pneumococcal carriage density and duration of colonization. LAIV and WT influenza virus infection.

LAIV enhances bacterial load and duration of staphylococcal carriage.

Figure 3: Possible effects of seasonality on a novel influenza strain.

Peter Palese, Terrence M. Tumpey, Adolfo Garcia-Sastre Immunity

Presentation transcript:

Schematic representation of the progress in the development of vaccines against the most recent pandemic and seasonal H1N1 influenza virus strains. Schematic representation of the progress in the development of vaccines against the most recent pandemic and seasonal H1N1 influenza virus strains. The use of adjuvants already allows the coverage of closely related strains with one vaccine. In the future, a universal vaccine may cover all strains. Antonio Cassone, and Rino Rappuoli mBio 2010; doi:10.1128/mBio.00042-10